30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

cbdMD Inc (YCBD)

Track

The most recent insider trading activity occurred on December 17, 2025, with significant sell transactions reported by Clark R. Crosnoe and related entities. These sales involved a substantial number of shares and a high total value, indicating a notable divestment. Prior to this, transactions were infrequent and dated back to 2021.
Stock chart
Ticker: YCBD Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Crosnoe Clark R.
3 sales — total 1,276,842 USD
Sale 17 Dec 2025
Value US$2,747,943.91 | Price 474.33 | Shares 30,296
Sale 17 Dec 2025
Value US$3,774,673.59 | Price 41.46 | Shares 3,063
Sale 17 Dec 2025
Value US$1,068,246.96 | Price 2.31 | Shares 461,725
Proposed sale 17 Dec 2025
Value US$850,740.56 | Price 279.63 | Shares 41,203
Buy 22 Jul 2021
Value US$0.00 | Price 0.00 | Shares 161,550
Sale 11 Mar 2021
Value US$257,564.32 | Price 3.93 | Shares 65,493
Sale 10 Mar 2021
Value US$240,116.70 | Price 4.04 | Shares 59,507
Sale 2 Mar 2021
Value US$80,748.00 | Price 4.04 | Shares 20,000
Sale 22 Feb 2021
Value US$518,805.00 | Price 4.25 | Shares 122,000
Sale 19 Feb 2021
Value US$12,845.70 | Price 4.28 | Shares 3,000
Sale 19 Feb 2021
Value US$1,059,970.56 | Price 4.42 | Shares 240,035
Sale 18 Feb 2021
Value US$500,767.96 | Price 4.43 | Shares 113,104
Sale 17 Feb 2021
Value US$192,764.45 | Price 4.54 | Shares 42,461
Sale 14 Aug 2020
Value US$34,300.00 | Price 3.43 | Shares 10,000
Buy 9 Mar 2020
Value US$18,720.00 | Price 0.75 | Shares 25,000
Buy 27 Jan 2020
Value US$5,300.00 | Price 1.06 | Shares 5,000
Buy 14 Jan 2020
Value US$125,000.00 | Price 1.00 | Shares 125,000
Buy 14 Jan 2020
Value US$15,000.00 | Price 1.00 | Shares 15,000
Buy 14 Jan 2020
Value US$10,000.00 | Price 1.00 | Shares 10,000
Buy 14 Jan 2020
Value US$20,000.00 | Price 1.00 | Shares 20,000
Buy 14 Jan 2020
Value US$125,000.00 | Price 1.00 | Shares 125,000
Buy 14 Jan 2020
Value US$125,000.00 | Price 1.00 | Shares 125,000
Buy 14 Jan 2020
Value US$15,000.00 | Price 1.00 | Shares 15,000
Buy 14 Jan 2020
Value US$20,000.00 | Price 1.00 | Shares 20,000
Sale 16 Apr 2019
Value US$2,332,000.00 | Price 4.00 | Shares 583,000
Sale 16 Apr 2019
Value US$1,132,000.00 | Price 4.00 | Shares 283,000
Sale 16 Apr 2019
Value US$666,668.00 | Price 4.00 | Shares 166,667
Sale 16 Apr 2019
Value US$100,000.00 | Price 4.00 | Shares 25,000
Sale 7 Mar 2019
Value US$1,303,336.00 | Price 4.00 | Shares 325,834
Sale 20 Feb 2019
Value US$600,000.00 | Price 4.00 | Shares 150,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-19 2025-12-17 S Sale
3.9
Crosnoe Clark R.
Large shareholder
30,296 +15.5%
474.33
US$2,747,944 		30,296 +15.5% 474.33 US$2,747,944
2025-12-19 2025-12-17 S Sale
3.9
Crosnoe Clark R.
Large shareholder
3,063 -35.8%
41.46
US$3,774,674 		3,063 -35.8% 41.46 US$3,774,674
2025-12-19 2025-12-17 S Sale
3.9
Crosnoe Clark R.
Large shareholder
19,453 -47.0%
374.77
US$816,405 		19,453 -47.0% 374.77 US$816,405
2025-12-17 2025-12-17 PrS Proposed sale
3.9
Clark R. Crosnoe, CRC Investment Fund LP, NM 2018 Trust dated April 4, 2018, AMC Legacy Trust dated December 21, 2012

Stockholder

Large shareholder
986,851
2.25
US$2,220,415 		986,851 2.25 US$2,220,415
2021-07-26 2021-07-22 B Purchase
Wiesehan John J III

Chief Revenue Officer

Officer
161,550
0.00
US$0 		161,550 0.00 US$0
2021-03-12 2021-03-11 S Sale
3.5
Sumichrast Martin A.

Chairman & CO-CEO

Executive Director
65,493 -4.4%
3.93
US$257,564 		65,493 -4.4% 3.93 US$257,564
2021-03-12 2021-03-10 S Sale
3.5
Sumichrast Martin A.

Chairman & CO-CEO

Executive Director
59,507 -3.8%
4.04
US$240,117 		59,507 -3.8% 4.04 US$240,117
2021-03-03 2021-03-02 S Sale
3.2
Raines William F III
Non-Executive Director
20,000 -93.7%
4.04
US$80,748 		20,000 -93.7% 4.04 US$80,748
2021-02-23 2021-02-22 S Sale
3.7
Coffman Raymond Scott

CO-CEO, President, Director

Executive Director Large shareholder
122,000 -100.0%
4.25
US$518,805 		122,000 -100.0% 4.25 US$518,805
2021-02-23 2021-02-19 S Sale
3.7
Coffman Raymond Scott

CO-CEO, President, Director

Executive Director Large shareholder
3,000 -2.4%
4.28
US$12,846 		3,000 -2.4% 4.28 US$12,846
2021-02-19 2021-02-19 S Sale
3.5
Sumichrast Martin A.

Chairman & CO-CEO

Executive Director
240,035 -100.0%
4.42
US$1,059,971 		240,035 -100.0% 4.42 US$1,059,971
2021-02-19 2021-02-18 S Sale
3.5
Sumichrast Martin A.

Chairman & CO-CEO

Executive Director
113,104 -32.0%
4.43
US$500,768 		113,104 -32.0% 4.43 US$500,768
2021-02-19 2021-02-17 S Sale
3.5
Sumichrast Martin A.

Chairman & CO-CEO

Executive Director
42,461 -10.7%
4.54
US$192,764 		42,461 -10.7% 4.54 US$192,764
2020-08-18 2020-08-14 S Sale
3.3
Sellers Bakari T.
Non-Executive Director
10,000 -79.8%
3.43
US$34,300 		10,000 -79.8% 3.43 US$34,300
2020-03-10 2020-03-09 B Purchase
2.8
Ghiloni Peter J.
25,000 +9.1%
0.75
US$18,720 		25,000 +9.1% 0.75 US$18,720
2020-02-25 2020-01-27 B Purchase
2.1
Elliott Mark S

CFO & COO
5,000 +10.7%
1.06
US$5,300 		5,000 +10.7% 1.06 US$5,300
2020-01-16 2020-01-14 B Purchase
3.7
Coffman Raymond Scott

CO-CEO
125,000 +1.0%
1.00
US$125,000 		125,000 +1.0% 1.00 US$125,000
2020-01-16 2020-01-14 B Purchase
1.6
Morris Gregory C
15,000 +592.7%
1.00
US$15,000 		15,000 +592.7% 1.00 US$15,000
2020-01-16 2020-01-14 B Purchase
3.3
Sellers Bakari T.
10,000 +395.1%
1.00
US$10,000 		10,000 +395.1% 1.00 US$10,000
2020-01-16 2020-01-14 B Purchase
1.6
Stephen Scott G.
20,000 +95.0%
1.00
US$20,000 		20,000 +95.0% 1.00 US$20,000
2020-01-16 2020-01-14 B Purchase
2.8
Ghiloni Peter J.
125,000 +83.3%
1.00
US$125,000 		125,000 +83.3% 1.00 US$125,000
2020-01-16 2020-01-14 B Purchase
3.5
Sumichrast Martin A.

CO-CEO
125,000 +46.2%
1.00
US$125,000 		125,000 +46.2% 1.00 US$125,000
2020-01-16 2020-01-14 B Purchase
2.1
Elliott Mark S

CFO & COO
15,000 +47.3%
1.00
US$15,000 		15,000 +47.3% 1.00 US$15,000
2020-01-16 2020-01-14 B Purchase
3.2
Raines William F III
20,000 +21.3%
1.00
US$20,000 		20,000 +21.3% 1.00 US$20,000
2019-04-17 2019-04-16 S Sale
0.7
Sterling Erik
Large shareholder
583,000 -100.0%
4.00
US$2,332,000 		583,000 -100.0% 4.00 US$2,332,000
2019-04-17 2019-04-16 S Sale
0.7
Sterling Erik
Large shareholder
283,000 -100.0%
4.00
US$1,132,000 		283,000 -100.0% 4.00 US$1,132,000
2019-04-17 2019-04-16 S Sale
0.7
Sterling Erik
Large shareholder
166,667 -100.0%
4.00
US$666,668 		166,667 -100.0% 4.00 US$666,668
2019-04-17 2019-04-16 S Sale
0.7
Sterling Erik
Large shareholder
25,000 -100.0%
4.00
US$100,000 		25,000 -100.0% 4.00 US$100,000
2019-03-08 2019-03-07 S Sale
3.5
Sumichrast Martin A.

Chairman of the Board and CEO
325,834 -54.6%
4.00
US$1,303,336 		325,834 -54.6% 4.00 US$1,303,336
2019-02-22 2019-02-20 S Sale
3.5
Sumichrast Martin A.

Chairman of the Board and CEO
150,000 -20.1%
4.00
US$600,000 		150,000 -20.1% 4.00 US$600,000
Explore more

More insider trading research around cbdMD Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America